Article
BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.
Human pathology - 1 May 2014
Walts Ann E, Pao Andy, Sacks Wendy, Bose Shikha
Abstract excerpt
Intratumoral heterogeneity is widely recognized as an important determinant of a cancer's initial response and its subsequent resistance to targeted therapy. BRAF V600E mutation, common in papillary thyroid carcinoma (PTC), is helpful in fine needle aspiration diagnosis of thyroid nodules and is being evaluated for targeted therapies. This study was designed to assess the presence of BRAF mutation heterogeneity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
